1. Home
  2. SCPH vs CPSS Comparison

SCPH vs CPSS Comparison

Compare SCPH & CPSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • CPSS
  • Stock Information
  • Founded
  • SCPH 2013
  • CPSS 1991
  • Country
  • SCPH United States
  • CPSS United States
  • Employees
  • SCPH N/A
  • CPSS N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • CPSS Finance: Consumer Services
  • Sector
  • SCPH Health Care
  • CPSS Finance
  • Exchange
  • SCPH Nasdaq
  • CPSS Nasdaq
  • Market Cap
  • SCPH 173.6M
  • CPSS 193.8M
  • IPO Year
  • SCPH 2017
  • CPSS 1992
  • Fundamental
  • Price
  • SCPH $3.84
  • CPSS $9.85
  • Analyst Decision
  • SCPH Strong Buy
  • CPSS
  • Analyst Count
  • SCPH 3
  • CPSS 0
  • Target Price
  • SCPH $14.00
  • CPSS N/A
  • AVG Volume (30 Days)
  • SCPH 289.6K
  • CPSS 16.0K
  • Earning Date
  • SCPH 08-13-2025
  • CPSS 07-29-2025
  • Dividend Yield
  • SCPH N/A
  • CPSS N/A
  • EPS Growth
  • SCPH N/A
  • CPSS N/A
  • EPS
  • SCPH N/A
  • CPSS 0.79
  • Revenue
  • SCPH $41,982,000.00
  • CPSS $188,776,000.00
  • Revenue This Year
  • SCPH $108.95
  • CPSS $146.82
  • Revenue Next Year
  • SCPH $73.83
  • CPSS $18.24
  • P/E Ratio
  • SCPH N/A
  • CPSS $12.38
  • Revenue Growth
  • SCPH 138.10
  • CPSS N/A
  • 52 Week Low
  • SCPH $1.94
  • CPSS $7.99
  • 52 Week High
  • SCPH $5.65
  • CPSS $12.73
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 56.83
  • CPSS 57.64
  • Support Level
  • SCPH $3.86
  • CPSS $9.45
  • Resistance Level
  • SCPH $4.17
  • CPSS $10.17
  • Average True Range (ATR)
  • SCPH 0.23
  • CPSS 0.24
  • MACD
  • SCPH -0.06
  • CPSS 0.01
  • Stochastic Oscillator
  • SCPH 33.33
  • CPSS 70.83

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

Share on Social Networks: